These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

867 related items for PubMed ID: 31473080

  • 1. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H, Liu X, Zhang C, Li Q, An X, Liu S, Wu L, Zhang B, Yuan Y, Xing C.
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [Abstract] [Full Text] [Related]

  • 2. Urinary mRNA Signatures as Predictors of Renal Function Decline in Patients With Biopsy-Proven Diabetic Kidney Disease.
    Lee YH, Seo JW, Kim M, Tae D, Seok J, Kim YG, Lee SH, Kim JS, Hwang HS, Jeong KH, Moon JY.
    Front Endocrinol (Lausanne); 2021 Nov; 12():774436. PubMed ID: 34858345
    [Abstract] [Full Text] [Related]

  • 3. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S, Chen J, Wu L, Nie G, Sun L, Zhang C, Huang Z, Xing C, Zhang B, Yuan Y.
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [Abstract] [Full Text] [Related]

  • 4. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S, Sun L, Nie G, Chen J, Zhang C, Zhu H, Huang Z, Qian J, Zhao X, Xing C, Zhang B, Yuan Y.
    Front Immunol; 2020 Oct; 11():2073. PubMed ID: 32983156
    [Abstract] [Full Text] [Related]

  • 5. Value of monitoring urine ammonia at time of biopsy in patients with lupus nephritis.
    Zhu H, Wan H, Duan S, Zhang C, Li Q, Liu S, Wu L, Zhang B, Xing C, Yuan Y.
    BMC Nephrol; 2020 Oct 20; 21(1):442. PubMed ID: 33081708
    [Abstract] [Full Text] [Related]

  • 6. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
    Wu L, Li XQ, Chang DY, Zhang H, Li JJ, Wu SL, Zhang LX, Chen M, Zhao MH.
    Nephrol Dial Transplant; 2020 Feb 01; 35(2):291-297. PubMed ID: 30357416
    [Abstract] [Full Text] [Related]

  • 7. Diabetic Nephropathy Can Be Treated with Calcium Dobesilate by Alleviating the Chronic Inflammatory State and Improving Endothelial Cell Function.
    Zhou Y, Qi C, Li S, Shao X, Mou S, Ni Z.
    Cell Physiol Biochem; 2018 Feb 01; 51(3):1119-1133. PubMed ID: 30476916
    [Abstract] [Full Text] [Related]

  • 8. Urinary biomarkers of tubular injury to predict renal progression and end stage renal disease in type 2 diabetes mellitus with advanced nephropathy: A prospective cohort study.
    Satirapoj B, Pooluea P, Nata N, Supasyndh O.
    J Diabetes Complications; 2019 Sep 01; 33(9):675-681. PubMed ID: 31227289
    [Abstract] [Full Text] [Related]

  • 9. A study of the natural history of diabetic kidney disease (DKD).
    Altemtam N, Russell J, El Nahas M.
    Nephrol Dial Transplant; 2012 May 01; 27(5):1847-54. PubMed ID: 22058177
    [Abstract] [Full Text] [Related]

  • 10. Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy-proven diabetic kidney disease: A multicenter cohort study.
    Shimizu M, Furuichi K, Toyama T, Yamanouchi M, Hoshino J, Kitajima S, Hara A, Iwata Y, Sakai N, Yuzawa Y, Kitamura H, Sato H, Shibagaki Y, Suzuki Y, Uesugi N, Ueda Y, Kohagura K, Samejima K, Tsuruya K, Nishi S, Nishino T, Makino H, Matsuo S, Ubara Y, Yokoyama H, Wada T, Research Group of Diabetic Nephropathy, the Ministry of Health, Labour and Welfare, and the Japan Agency for Medical Research and Development.
    J Diabetes Investig; 2023 Nov 01; 14(11):1268-1278. PubMed ID: 37483063
    [Abstract] [Full Text] [Related]

  • 11. Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.
    Afkarian M, Zelnick LR, Ruzinski J, Kestenbaum B, Himmelfarb J, de Boer IH, Mehrotra R.
    J Diabetes Complications; 2015 Nov 01; 29(8):1024-31. PubMed ID: 26412030
    [Abstract] [Full Text] [Related]

  • 12. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM, Murakami T, Oakes ML, Mitsuhashi M, Kelly C, Henry RR, Sharma K.
    Am J Nephrol; 2018 Nov 01; 47(5):283-291. PubMed ID: 29779026
    [Abstract] [Full Text] [Related]

  • 13. Association between Urine Ammonium and Urine TGF-β1 in CKD.
    Raphael KL, Gilligan S, Hostetter TH, Greene T, Beddhu S.
    Clin J Am Soc Nephrol; 2018 Feb 07; 13(2):223-230. PubMed ID: 29146699
    [Abstract] [Full Text] [Related]

  • 14. Identification of Novel Urinary Biomarkers for Predicting Renal Prognosis in Patients With Type 2 Diabetes by Glycan Profiling in a Multicenter Prospective Cohort Study: U-CARE Study 1.
    Mise K, Imamura M, Yamaguchi S, Teshigawara S, Tone A, Uchida HA, Eguchi J, Nakatsuka A, Ogawa D, Yoshida M, Yamada M, Shikata K, Wada J.
    Diabetes Care; 2018 Aug 07; 41(8):1765-1775. PubMed ID: 29930140
    [Abstract] [Full Text] [Related]

  • 15. Increased urinary miR-196a level predicts the progression of renal injury in patients with diabetic nephropathy.
    An Y, Zhang C, Xu F, Li W, Zeng C, Xie L, Liu Z.
    Nephrol Dial Transplant; 2020 Jun 01; 35(6):1009-1016. PubMed ID: 30521014
    [Abstract] [Full Text] [Related]

  • 16. Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes.
    Vaisar T, Durbin-Johnson B, Whitlock K, Babenko I, Mehrotra R, Rocke DM, Afkarian M.
    Diabetes Care; 2018 Nov 01; 41(11):2361-2369. PubMed ID: 30150236
    [Abstract] [Full Text] [Related]

  • 17. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
    Yamanouchi M, Furuichi K, Shimizu M, Toyama T, Yamamura Y, Oshima M, Kitajima S, Hara A, Iwata Y, Sakai N, Oba Y, Matsuoka S, Ikuma D, Mizuno H, Suwabe T, Hoshino J, Sawa N, Yuzawa Y, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ueda Y, Nishi S, Yokoyama H, Nishino T, Samejima K, Kohagura K, Shibagaki Y, Makino H, Matsuo S, Ubara Y, Wada T.
    Nephrol Dial Transplant; 2022 Feb 25; 37(3):489-497. PubMed ID: 34028524
    [Abstract] [Full Text] [Related]

  • 18. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y, Zhao L, Zhang J, Wang Y, Wu Y, Ren H, Wang T, Zhang R, Wang J, Zhao Y, Qin C, Xu H, Li L, Chai Z, Cooper ME, Tong N, Liu F.
    Ren Fail; 2022 Dec 25; 44(1):562-570. PubMed ID: 35373711
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy.
    Wei J, Wang B, Shen FJ, Zhang TT, Duan Z, Zhou DM.
    BMC Nephrol; 2022 Jul 27; 23(1):270. PubMed ID: 35896961
    [Abstract] [Full Text] [Related]

  • 20. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.
    Wang X, Ren L, Huang Y, Feng Z, Zhang G, Dai H.
    Clin Chim Acta; 2023 Jul 01; 547():117448. PubMed ID: 37331550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.